ID   STK16_HUMAN             Reviewed;         305 AA.
AC   O75716; A8K9H9; Q5U0F8; Q96KI2; Q9BUH4; Q9UEN3; Q9UP78;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   12-APR-2017, entry version 169.
DE   RecName: Full=Serine/threonine-protein kinase 16;
DE            EC=2.7.11.1;
DE   AltName: Full=Myristoylated and palmitoylated serine/threonine-protein kinase;
DE            Short=MPSK;
DE   AltName: Full=Protein kinase PKL12;
DE   AltName: Full=TGF-beta-stimulated factor 1;
DE            Short=TSF-1;
DE   AltName: Full=Tyrosine-protein kinase STK16;
DE            EC=2.7.10.2;
DE   AltName: Full=hPSK;
GN   Name=STK16; Synonyms=MPSK1, PKL12, TSF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9712705; DOI=10.1006/bbrc.1998.9163;
RA   Ligos J.M., Gerwin N., Fernandez P., Gutierrez-Ramos J.-C., Bernad A.;
RT   "Cloning, expression analysis, and functional characterization of
RT   PKL12, a member of a new subfamily of ser/thr kinases.";
RL   Biochem. Biophys. Res. Commun. 249:380-384(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, FUNCTION,
RP   AUTOPHOSPHORYLATION, MYRISTOYLATION AT GLY-2, PALMITOYLATION AT CYS-6
RP   AND CYS-8, AND MUTAGENESIS OF GLY-2; CYS-6 AND CYS-8.
RC   TISSUE=Dendritic cell;
RX   PubMed=10364453; DOI=10.1006/bbrc.1999.0811;
RA   Berson A.E., Young C., Morrison S.L., Fujii G.H., Sheung J., Wu B.,
RA   Bolen J.B., Burkhardt A.L.;
RT   "Identification and characterization of a myristylated and
RT   palmitylated serine/threonine protein kinase.";
RL   Biochem. Biophys. Res. Commun. 259:533-538(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10947953; DOI=10.1042/bj3500395;
RA   Ohta S., Takeuchi M., Deguchi M., Tsuji T., Gahara Y., Nagata K.;
RT   "A novel transcriptional factor with Ser/Thr kinase activity involved
RT   in the transforming growth factor (TGF)-beta signalling pathway.";
RL   Biochem. J. 350:395-404(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RA   Wabakken T.K., Aasheim H.-C.;
RT   "Characterization of a ubiquitous expressed human serine/threonine
RT   kinase.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Stairs D.B., Ha S.I., Chodosh L.A.;
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TRP-266.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TRP-266.
RC   TISSUE=Colon, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 13-304 OF WILD TYPE AND IN
RP   COMPLEX WITH STAUROSPORINE, SUBUNIT, INTERACTION WITH DRG1,
RP   PHOSPHORYLATION AT THR-185; SER-197 AND TYR-198, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=18184589; DOI=10.1016/j.str.2007.10.026;
RA   Eswaran J., Bernad A., Ligos J.M., Guinea B., Debreczeni J.E.,
RA   Sobott F., Parker S.A., Najmanovich R., Turk B.E., Knapp S.;
RT   "Structure of the human protein kinase MPSK1 reveals an atypical
RT   activation loop architecture.";
RL   Structure 16:115-124(2008).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-41; LYS-55; VAL-77; TRP-266 AND
RP   LEU-277.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Membrane-associated protein kinase that phosphorylates
CC       on serine and threonine residues. In vitro substrates include
CC       DRG1, ENO1 and EIF4EBP1. Also autophosphorylates. May be involved
CC       in secretory vesicle trafficking or intracellular signaling. May
CC       have a role in regulating stromal-epithelial interactions that
CC       occur during ductal morphogenesis in the mammary gland. May be
CC       involved in TGF-beta signaling. Able to autophosphorylate on Tyr
CC       residue; it is however unclear whether it has tyrosine-protein
CC       kinase toward other proteins. {ECO:0000269|PubMed:10364453}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10027}.
CC   -!- SUBUNIT: Monomer. Interacts with DRG1 (via its N-terminal); the
CC       interaction phosphorylates DRG1. {ECO:0000269|PubMed:18184589}.
CC   -!- INTERACTION:
CC       Q6UY14:ADAMTSL4; NbExp=3; IntAct=EBI-749295, EBI-742002;
CC       Q08117:AES; NbExp=3; IntAct=EBI-749295, EBI-717810;
CC       Q96Q35:ALS2CR12; NbExp=3; IntAct=EBI-749295, EBI-750451;
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-749295, EBI-739580;
CC       O43186:CRX; NbExp=3; IntAct=EBI-749295, EBI-748171;
CC       Q96EY1-2:DNAJA3; NbExp=3; IntAct=EBI-749295, EBI-3952284;
CC       Q9Y295:DRG1; NbExp=3; IntAct=EBI-749295, EBI-719554;
CC       O95967:EFEMP2; NbExp=5; IntAct=EBI-749295, EBI-743414;
CC       Q5JST6:EFHC2; NbExp=3; IntAct=EBI-749295, EBI-2349927;
CC       Q9UKT9:IKZF3; NbExp=3; IntAct=EBI-749295, EBI-747204;
CC       Q0VD86:INCA1; NbExp=5; IntAct=EBI-749295, EBI-6509505;
CC       Q9BQ13:KCTD14; NbExp=3; IntAct=EBI-749295, EBI-10189448;
CC       Q8N5Z5:KCTD17; NbExp=6; IntAct=EBI-749295, EBI-743960;
CC       Q8N5Z5-2:KCTD17; NbExp=3; IntAct=EBI-749295, EBI-10189368;
CC       P60370:KRTAP10-5; NbExp=3; IntAct=EBI-749295, EBI-10172150;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-749295, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-749295, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-749295, EBI-10172052;
CC       Q6PEX3:KRTAP26-1; NbExp=3; IntAct=EBI-749295, EBI-3957672;
CC       A4D127:MEOX2; NbExp=3; IntAct=EBI-749295, EBI-10172134;
CC       Q5JXC2:MIIP; NbExp=3; IntAct=EBI-749295, EBI-2801965;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-749295, EBI-742948;
CC       Q9GZT8:NIF3L1; NbExp=3; IntAct=EBI-749295, EBI-740897;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-749295, EBI-945833;
CC       Q92824:PCSK5; NbExp=3; IntAct=EBI-749295, EBI-751290;
CC       O15162:PLSCR1; NbExp=3; IntAct=EBI-749295, EBI-740019;
CC       Q9NRY6:PLSCR3; NbExp=5; IntAct=EBI-749295, EBI-750734;
CC       Q04864:REL; NbExp=3; IntAct=EBI-749295, EBI-307352;
CC       Q8HWS3:RFX6; NbExp=3; IntAct=EBI-749295, EBI-746118;
CC       P49247:RPIA; NbExp=4; IntAct=EBI-749295, EBI-744831;
CC       Q8IYX7:SAXO1; NbExp=5; IntAct=EBI-749295, EBI-3957636;
CC       P12757:SKIL; NbExp=3; IntAct=EBI-749295, EBI-2902468;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-749295, EBI-742487;
CC       Q99081:TCF12; NbExp=3; IntAct=EBI-749295, EBI-722877;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-749295, EBI-533224;
CC       Q7DB77:tir (xeno); NbExp=3; IntAct=EBI-749295, EBI-6480811;
CC       Q13829:TNFAIP1; NbExp=3; IntAct=EBI-749295, EBI-2505861;
CC       O43734:TRAF3IP2; NbExp=3; IntAct=EBI-749295, EBI-744798;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-749295, EBI-719493;
CC       A1L4B6:TRIM42; NbExp=3; IntAct=EBI-749295, EBI-10172216;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-749295, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Membrane
CC       {ECO:0000250}; Lipid-anchor {ECO:0000250}. Note=Associates with
CC       Golgi and Golgi-derived vesicles. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed at very low levels.
CC       {ECO:0000269|PubMed:10364453}.
CC   -!- PTM: Mainly autophosphorylated on serine/threonine residues. Also
CC       autophosphorylated on Tyr-198. {ECO:0000269|PubMed:18184589}.
CC   -!- PTM: It is uncertain whether palmitoylation is on Cys-6 and/or
CC       Cys-8. {ECO:0000269|PubMed:10364453}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAV38392.1; Type=Frameshift; Positions=305; Evidence={ECO:0000305};
CC       Sequence=CAA06700.1; Type=Frameshift; Positions=305; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ005791; CAA06700.1; ALT_FRAME; mRNA.
DR   EMBL; AF060798; AAC28337.1; -; mRNA.
DR   EMBL; AB020739; BAB16311.1; -; mRNA.
DR   EMBL; AJ010872; CAA09387.1; -; mRNA.
DR   EMBL; AF203910; AAG23728.1; -; mRNA.
DR   EMBL; BT019585; AAV38392.1; ALT_FRAME; mRNA.
DR   EMBL; AK292694; BAF85383.1; -; mRNA.
DR   EMBL; CR407675; CAG28603.1; -; mRNA.
DR   EMBL; BC002618; AAH02618.1; -; mRNA.
DR   EMBL; BC053998; AAH53998.1; -; mRNA.
DR   CCDS; CCDS42822.1; -.
DR   RefSeq; NP_001008910.1; NM_001008910.3.
DR   RefSeq; NP_001317142.1; NM_001330213.1.
DR   UniGene; Hs.153003; -.
DR   PDB; 2BUJ; X-ray; 2.60 A; A/B=13-305.
DR   PDBsum; 2BUJ; -.
DR   ProteinModelPortal; O75716; -.
DR   SMR; O75716; -.
DR   BioGrid; 114144; 69.
DR   DIP; DIP-29598N; -.
DR   IntAct; O75716; 73.
DR   MINT; MINT-3001680; -.
DR   STRING; 9606.ENSP00000379964; -.
DR   BindingDB; O75716; -.
DR   ChEMBL; CHEMBL3938; -.
DR   GuidetoPHARMACOLOGY; 2213; -.
DR   iPTMnet; O75716; -.
DR   PhosphoSitePlus; O75716; -.
DR   SwissPalm; O75716; -.
DR   BioMuta; STK16; -.
DR   EPD; O75716; -.
DR   PaxDb; O75716; -.
DR   PeptideAtlas; O75716; -.
DR   PRIDE; O75716; -.
DR   DNASU; 8576; -.
DR   Ensembl; ENST00000396738; ENSP00000379964; ENSG00000115661.
DR   Ensembl; ENST00000409638; ENSP00000386928; ENSG00000115661.
DR   GeneID; 8576; -.
DR   KEGG; hsa:8576; -.
DR   UCSC; uc002vko.3; human.
DR   CTD; 8576; -.
DR   GeneCards; STK16; -.
DR   HGNC; HGNC:11394; STK16.
DR   HPA; HPA029450; -.
DR   MIM; 604719; gene.
DR   neXtProt; NX_O75716; -.
DR   OpenTargets; ENSG00000115661; -.
DR   PharmGKB; PA36202; -.
DR   eggNOG; KOG2345; Eukaryota.
DR   eggNOG; ENOG410YN06; LUCA.
DR   GeneTree; ENSGT00550000075037; -.
DR   HOVERGEN; HBG054359; -.
DR   InParanoid; O75716; -.
DR   KO; K08856; -.
DR   PhylomeDB; O75716; -.
DR   TreeFam; TF350433; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; O75716; -.
DR   ChiTaRS; STK16; human.
DR   EvolutionaryTrace; O75716; -.
DR   GeneWiki; STK16; -.
DR   GenomeRNAi; 8576; -.
DR   PRO; PR:O75716; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115661; -.
DR   CleanEx; HS_STK16; -.
DR   ExpressionAtlas; O75716; baseline and differential.
DR   Genevisible; O75716; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Lipoprotein; Membrane; Myristate; Nucleotide-binding; Palmitate;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    305       Serine/threonine-protein kinase 16.
FT                                /FTId=PRO_0000086701.
FT   DOMAIN       20    293       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      26     34       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      166    202       Activation loop.
FT   ACT_SITE    148    148       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      49     49       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     185    185       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18184589}.
FT   MOD_RES     197    197       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18184589}.
FT   MOD_RES     198    198       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18184589}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:10364453}.
FT   LIPID         6      6       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:10364453}.
FT   LIPID         8      8       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:10364453}.
FT   VARIANT      41     41       H -> R (in dbSNP:rs34799131).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041140.
FT   VARIANT      55     55       E -> K (in dbSNP:rs35947471).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041141.
FT   VARIANT      77     77       I -> V (in dbSNP:rs34282267).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041142.
FT   VARIANT     266    266       R -> W (in dbSNP:rs17849638).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_041143.
FT   VARIANT     277    277       P -> L (in dbSNP:rs35454203).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041144.
FT   MUTAGEN       2      2       G->A: Loss of myristoylation.
FT                                {ECO:0000269|PubMed:10364453}.
FT   MUTAGEN       6      6       C->S: Loss of palmitoylation.
FT                                {ECO:0000269|PubMed:10364453}.
FT   MUTAGEN       8      8       C->S: Loss of palmitoylation.
FT                                {ECO:0000269|PubMed:10364453}.
FT   CONFLICT     59     59       R -> L (in Ref. 6; AAV38392).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       S -> P (in Ref. 7; BAF85383).
FT                                {ECO:0000305}.
FT   CONFLICT    213    213       D -> G (in Ref. 1; CAA06700 and 4;
FT                                CAA09387). {ECO:0000305}.
FT   CONFLICT    221    221       L -> F (in Ref. 2; AAC28337).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       G -> S (in Ref. 4; CAA09387).
FT                                {ECO:0000305}.
FT   STRAND       13     15       {ECO:0000244|PDB:2BUJ}.
FT   STRAND       18     27       {ECO:0000244|PDB:2BUJ}.
FT   STRAND       32     39       {ECO:0000244|PDB:2BUJ}.
FT   TURN         40     42       {ECO:0000244|PDB:2BUJ}.
FT   STRAND       45     55       {ECO:0000244|PDB:2BUJ}.
FT   HELIX        56     70       {ECO:0000244|PDB:2BUJ}.
FT   STRAND       82     88       {ECO:0000244|PDB:2BUJ}.
FT   STRAND       91     99       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       106    114       {ECO:0000244|PDB:2BUJ}.
FT   TURN        115    117       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       122    141       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       151    153       {ECO:0000244|PDB:2BUJ}.
FT   STRAND      154    156       {ECO:0000244|PDB:2BUJ}.
FT   STRAND      162    164       {ECO:0000244|PDB:2BUJ}.
FT   STRAND      171    173       {ECO:0000244|PDB:2BUJ}.
FT   STRAND      175    179       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       180    193       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       196    198       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       201    203       {ECO:0000244|PDB:2BUJ}.
FT   STRAND      208    212       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       215    230       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       236    240       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       245    250       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       263    272       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       277    279       {ECO:0000244|PDB:2BUJ}.
FT   HELIX       283    292       {ECO:0000244|PDB:2BUJ}.
SQ   SEQUENCE   305 AA;  34656 MW;  593B2AEB8505009C CRC64;
     MGHALCVCSR GTVIIDNKRY LFIQKLGEGG FSYVDLVEGL HDGHFYALKR ILCHEQQDRE
     EAQREADMHR LFNHPNILRL VAYCLRERGA KHEAWLLLPF FKRGTLWNEI ERLKDKGNFL
     TEDQILWLLL GICRGLEAIH AKGYAHRDLK PTNILLGDEG QPVLMDLGSM NQACIHVEGS
     RQALTLQDWA AQRCTISYRA PELFSVQSHC VIDERTDVWS LGCVLYAMMF GEGPYDMVFQ
     KGDSVALAVQ NQLSIPQSPR HSSALRQLLN SMMTVDPHQR PHIPLLLSQL EALQPPAPGQ
     HTTQI
//
